Top 50 Medical Startup Investors in Austria in September 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Austria. We rank investors based on the number of investments they made in Medical companies from Austria. We update this investor list every month.Top 50 Medical Startup Investors in Austria in September 2025
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Medical Device
- Seed, Pre-Seed, Series A
- Austria, France, Slovenia
Portfolio highlights
- Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Series A, Series B, Seed
- United States, India, Singapore
Portfolio highlights
- DePoly — DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. Weexpect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
- CloudSEK — CloudSEK leverages contextual AI to predict and prevent cyber threats. Keep your organisation safe and secure.
- Griffin — Griffin is making a bank you can build on. They provide banking-as-a-service solutions for companies that want to offer financial services products. The company is currently seeking regulatory approval from the PRA and FCA to become the UK's first platform bank. It was founded in 2017 and based in London, England.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- ASTRA Therapeutics — Astra - Therapeutics
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Austria, United States, Germany
Portfolio highlights
- Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
- NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
- byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
Rene Schneider
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Seed, Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Entrepreneurs for Entrepreneurs
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Funding Round
- Austria, Switzerland
Portfolio highlights
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- Teragon — Laser Metrology for Steel Rolling Mills. Engineered in Graz, Austria.
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
MMC is a venture capital fund investing in early stage, high-growth UK companies. Investing in technology companies at Seed and Series A.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series A, Seed, Series B
- United Kingdom, United States, France
Portfolio highlights
- BlackWall — Protect your web site from hacking, content theft, crawling, and cloning!
- ABEX — ABEX Capital focuses on algorithmic trading for digital assets using machine learning and high-frequency trading engines. It offers "Algorithmic Best Execution" solutions for institutional clients and is registered with the FCA for cryptoasset activities
- Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Multi family office investing in proptech, digital health & sustainability
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Series A, Pre-Seed
- Austria, Germany
Portfolio highlights
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Dr. Johann ‘Hansi’ Hansmann was born in Austria and studied economics in Vienna. He spent the major part of his professional life working as an executive in the pharmaceutical industry in Austria, Germany, UK and Spain. He gathered several years of entrepreneurial experience running successfully his own pharmaceutical company in Spain afterconducting a management buy-out of a big pharmaceutical plant, making an exit in 2003. Since this time he is active as investor and business angel. He currently holds investments with a geographical focus on Austria, Germany, UK and Spain both internet and in the health industry. He led Runtastic, shpock, mysugr and just recently durchblicker and Busuu to extraordinary exits. He was president of the ‘Austrian Angels Investors Association’ until 2021, was awarded 'Best European Early Stage Investor' in 2016 by eban.org and is now based in Vienna and tries to find spare time to ride his mountain bike.
Show more
Investment focus
- Software, Health Care, Fitness
- Seed, Angel, Pre-Seed
- Austria, United Kingdom, Spain
Portfolio highlights
- fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
- Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
- Shopstory — boomerank is a SaaS that helps eCommerce companies grow automatically with help of a powerful AI and the creation of an immense data hub.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Grant, Pre-Seed
- Austria, Belgium
Portfolio highlights
- HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
- Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
- revitalyze — revitalyze - AI Assistant for Construction
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series B, Funding Round, Series C
- United States, Germany, Switzerland
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
- Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more
Investment focus
- Sensor, Medical, Wireless
- Series B, Funding Round
- Austria
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
The typical market transaction involves the sale of one company at a time. However, there are situations where disposing of holdings in a number of businesses, in a single transaction, brings significant benefits - together with substantial time and cost efficiencies.Whether seeking a solution to illiquidity, the disposal of legacy assets orthe freedom to implement strategic change, Nova offers the corporate and financial sellers an efficient and market value solution. Unlocked from their holdings, investors and owners are better positioned to focus on the benefits and opportunities this significant step change brings.Although principally an acquirer, Nova can also work with investors in private equity funds, where there is the need for a Replacement Manager or General Partner.
Show more
Investment focus
- Software, Artificial Intelligence, Automotive
- Seed, Series A, Series C
- Italy, Poland, Austria
Portfolio highlights
- Roboze — Roboze is able to engineer high performance thermoplastic polymers resistant to the most extreme operating conditions for various sectors.
- contextflow — contextflow revolutionizes the medical information search process with the help of deep learning: our 3D image-based search engine for radiologists looks for regions of interest within images (currently 18+ patterns in lung CTs); when a suspicious pattern is detected, we immediately find visually similar cases, descriptions and relevant referenceinformation, affording doctors easy access to knowledge currently hidden in large medical image data and their associated reports...all within seconds. No more paging through books, guessing the right keyword or consulting various text-based reference search engines. In addition, our software can be configured to allow for prioritization of cases where patterns of interest are detected.contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by a team of AI and engineering experts in July 2016, the company was awarded the distinction of Most Promising Startup by the BCS Search Industry, received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research and was selected as one of 19 startups out of over 700 applications to participate in the Philips HealthWorks accelerator program. It is currently testing its 3D image-based software with six partners, expanding internationally to other locations later this year.
- Cardiomatics — Cardiomatics is a cloud AI tool for ECG analysis.Simply give us a raw ECG signal and our algorithms will turn it into valuable analysis.
Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Sweden
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds Radiology — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more
Investment focus
- Electronics, Software, Medical Device
- Funding Round, Seed, Series A
- Germany, Austria
Portfolio highlights
- Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
- Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Series C, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Series B, Series A
- United States, Germany, United Kingdom
Portfolio highlights
- Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
- Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Series C
- Austria, Germany
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more
Investment focus
- Software, Health Care, Medical
- Seed, Series A, Funding Round
- United States, Japan, Germany
Portfolio highlights
- Instalimb — Instalimb is the world's first 3D printing prosthesis business.
- CROSS SYNC — The company was founded in October 2019 by Dr. Takaki, a Japanese intensivist with more than 20-year experience in critical care medicine, from his strong desire of wanting to decrease preventable death and sudden changes in patient conditions while in the ICU. CROSS SYNC’s vision is to provide ICU-level medical treatment anywhere. The mission isto help and assist medical professionals utilizing the power of technology so that they can provide high-quality medical care even in an environment where there is a shortage of specialist physicians, and to ensure the best patient outcomes. As a Yokohama University certified startup, CROSS SYNC develops a variety of AI clinical assistant tools in collaboration with affiliated hospitals, the school of medicine, and the department of health data science. By delivering our AI-based platform to acute care settings all over the world, we aim to create a world without avoidable deaths and preventable acute changes for in-patients.
- EMobi — EMoBi is a transportation company that provides freight transport, and electric vehicle services with reservation facilities.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.
Show more
Investment focus
- Mobile, iOS, Mobile Apps
- Series A, Seed, Series C
- Austria, Switzerland, United States
Portfolio highlights
- Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.
Investor
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more
Investment focus
- Financial Services, FinTech, Information Technology
- Series A, Seed, Series B
- Singapore, India, United States
Portfolio highlights
- Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
- Aspire — Multi currency business account, for start-ups & SMEs, to manage your company spends & expenses, accounts receivables & payables, invoices, bills, corporate cards & cross-border payments.
- Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort
| Investments that move industries
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Austria, Germany, United States
Portfolio highlights
- Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more
Investment focus
- Artificial Intelligence, Health Care, Life Science
- Seed, Series A, Pre-Seed
- Germany, Austria
Portfolio highlights
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- voize — voize is an app for care documentation via voice input.
- DejaBlue — DejaBlue delivers a smart EV charging platform that supports solar integration, reduces energy costs, and improves site operations. Easily connect chargers, manage your fleet, and optimize performance with reliable tools built for scale.
- Lyceum — Introducing the smartest way to train your models in the cloud. The electricity socket for your infrastructure needs.
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Corporate Round, Post-IPO Debt, Series A
- United States, Austria
Portfolio highlights
- Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
- invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.
Show more
Investment focus
- Software, Biotechnology, Telecommunications
- Funding Round, Seed
- Austria, Germany
Portfolio highlights
- Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
- a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
Identifying opportunities for investors and providing capital for cutting-edge innovations in the oral and systemic health sectors.
Show more
Investment focus
- Health Care, Dental, Software
- Seed, Pre-Seed, Series A
- United States, The Netherlands, Austria
Portfolio highlights
- Odne — Curing with light
- Peerlogic — Peerlogic is the first conversational intelligence platform built for dental offices. The analytics platform provides detailed conversational insights between the practice and the patient. Conversational analytics, also known as call analytics, is the process of analyzing data points captured from human speech. It helps to identify trends,predict revenue outcomes, and provide best practices. The result is actionable intelligence that improves the dental practice’s bottom line. Conversational analytics can be used to adjust business strategy. Data provides the "why" behind what's working, what's not. By understanding the "why" practice owners are empowered with data-driven information that can be used to adjust business goals, objectives and tactics.
- OrthoPulse — OrthoPulse is a medical device manufacturer that produces dental care equipment, treatment control apps, and photo biomodulation solutions.
J&T Ventures is an early-stage Prague-based Venture Capital fund, which invests in promising startups from the CEE and SEE region. Our strategy is industry agnostic, but we primarily focus on companies in the seed stage with proven product market fit. Our average ticket size is between EUR 0.5m - EUR 2.5m.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Funding Round, Series A
- Czech Republic, United States, Croatia
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Wultra — Wultra helps the leading banks and fintech companies to secure their digital systems and bring trust to the customer journeys. Our security-related software technologies cover the whole digital banking application stack, be it on the web or mobile platforms.
- Grid.online — Grid.online is building transportation infrastructure as a service that will unlock the huge free transportation capacity of cities and allow it to be shared efficiently.
Lead Ventures is a Budapest-based venture capital firm, specialist of financing scale-ups in Central Europe. Its mission is to support the region’s most promising ventures with capital, experience and a wide-ranging professional network, enabling them to transform their industry with innovation. Lead Ventures provides equity financing tocompanies in their scale-up phase, the typical ticket size is between EUR 2-10 million. Lead Ventures is searching for dynamic teams with a unique story, outstanding growth potential and solutions tested and validated by the market. The firm seeks to invest in companies operating in the mobility, energy and sustainability as well as b2b services and software sectors, however, Lead Ventures is open to support teams active in other areas as well.Lead Ventures has EUR 200 million under management invested by MOL, the most successful energy company in CEE, and two financial institutions specialised in supporting the startup ecosystem - the Hungarian Development Bank (MFB) and Eximbank.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Series A, Seed, Series B
- Hungary, United Kingdom, Croatia
Portfolio highlights
- Oxla — Meet Oxla, the world's fastest-distributed database, designed to handle large amounts of data with ease.
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- RedTrack.io — RedTrack.io offers real-time access to your media buying KPIs/data: ad tracking, impressions, clicks, conversions across multiple channels & 30 data points.
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Biopart
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more
Investment focus
- Health Care, Medical Device, Internet of Things
- Series A, Seed, Funding Round
- Finland, Austria, United States
Portfolio highlights
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Inflection.io — Marketing technology for product-led companies
- Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
- Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
- Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Led by Werner Lanthaler, Wlanholding invests in life sciences and sustainability, advancing innovation and growth in cutting-edge technologies.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Austria
Portfolio highlights
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Rafael Vartian
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Germany
Portfolio highlights
- CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
- EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- Germany, Austria, Ireland
Portfolio highlights
- Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
- Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
FCPG Affi
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
China
Sri Lanka
Singapore
Qatar
Asia
Indonesia
Vietnam
Oceania
LATAM
Middle East
Europe
Bulgaria
Belize
Bahrain
Croatia
Georgia
Belarus
Hungary
France
Ghana
Ethiopia
Gibraltar
Chile
Egypt
Finland
Costa Rica
Greece
Barbados
Belgium
Estonia
Bermuda
Czech Republic
Denmark
Algeria
Hong Kong
Ecuador
Faroe Islands
Liechtenstein
Liberia
Lebanon
Mauritius
Peru
Norway
Israel
Malaysia
Mexico
Nicaragua
Jersey
Panama
Morocco
Mali
Lithuania
Italy
Philippines
Kuwait
Malta
Myanmar
Sierra Leone
El Salvador
Uganda
Venezuela
Sweden
Slovenia
Poland
Uruguay
Ukraine
Tajikistan
Puerto Rico
Portugal
Tunisia
Taiwan
Tanzania
Turkey
San Marino
Senegal
Togo
Uzbekistan
Serbia
Russian Federation
Zambia
Rwanda
Zimbabwe
Thailand
Dominican Republic
Azerbaijan
Iceland
Nigeria
Bahamas
Namibia
Iraq
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Grenada
Jordan
Romania
Bangladesh
Argentina
Saudi Arabia
Brazil
Kazakhstan
Kenya
Cayman Islands
Cambodia
Guatemala
Oman
Latvia
Cyprus
Austria
Switzerland
Cameroon
Colombia
Seychelles
Marshall Islands
Investors in Austria by industry
Transportation
Music
Cryptocurrency
Education
Finance
Food and Beverage
Real Estate
Organic Food
Medical
Internet
Manufacturing
Wellness
Digital Media
Android
Mobile
Blockchain
Local
Software
Enterprise Software
Sports
eSports
Fitness
Automotive
Hospitality
Travel
InsurTech
Platforms
Recruiting
FinTech
Biotechnology
Consumer
Health Care
EdTech
Energy
Sustainability
Climate
Impact
Marketplace
Proptech
SaaS
Artificial intelligence
Hardware
Gaming
Mobile Apps
Web3
B2B
Life Science
Sporting Goods
Publishing
Financial Services
Renewable Energy
Biotech
Enterprise
Medical Device
Big Data
Social Impact
Social Media
Art
Agriculture (agtech)
Machine Learning
Media (entertainment)
Construction
Community
CleanTech
Retail
Payments